deltatrials
Unknown OBSERVATIONAL NCT03334552

Identification of Broadly HIV-1 Neutralizing Antibodies (bNAb) in HIV-infected Patients in Mbeya, Tanzania. (bNAb)

Sponsor: Max von Pettenkofer-Institute of the University of Munich (LMU), Department of Virology

Conditions HIV/AIDS
Updated 19 times since 2017 Last updated: Nov 27, 2023 Started: Oct 15, 2017 Primary completion: May 31, 2024 Completion: Aug 31, 2024
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on HIV/AIDS, this trial is ongoing. The trial is conducted by Max von Pettenkofer-Institute of the University of Munich (LMU), Department of Virology and has accumulated 19 data snapshots since 2017. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Aug 2018 · 2 months · monthly snapshot~Aug 2018 – ~Mar 2019 · 7 months · monthly snapshot~Mar 2019 – ~Jul 2019 · 4 months · monthly snapshot~Jul 2019 – ~Mar 2020 · 8 months · monthly snapshot~Mar 2020 – ~Sep 2020 · 6 months · monthly snapshot~Sep 2020 – ~Jan 2021 · 4 months · monthly snapshot~Jan 2021 – ~Mar 2021 · 59 days · monthly snapshot~Mar 2021 – ~Sep 2021 · 6 months · monthly snapshot~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshot~Mar 2022 – ~Sep 2022 · 6 months · monthly snapshot~Sep 2022 – ~Apr 2023 · 7 months · monthly snapshot~Apr 2023 – ~Jun 2023 · 2 months · monthly snapshot~Jun 2023 – ~Dec 2023 · 6 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Jan 2026 · 16 months · monthly snapshot~Jan 2026 – present · 7 months · monthly snapshot

Change History

19 versions recorded

  1. Jan 2026 — Present [monthly]

    Unknown

    Status: Active Not Recruiting → Unknown

  2. Sep 2024 — Jan 2026 [monthly]

    Active Not Recruiting

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting

  4. Dec 2023 — Jul 2024 [monthly]

    Active Not Recruiting

  5. Jun 2023 — Dec 2023 [monthly]

    Active Not Recruiting

▶ Show 14 earlier versions

  1. Apr 2023 — Jun 2023 [monthly]

    Active Not Recruiting

  2. Sep 2022 — Apr 2023 [monthly]

    Active Not Recruiting

  3. Mar 2022 — Sep 2022 [monthly]

    Active Not Recruiting

  4. Sep 2021 — Mar 2022 [monthly]

    Active Not Recruiting

  5. Mar 2021 — Sep 2021 [monthly]

    Active Not Recruiting

  6. Jan 2021 — Mar 2021 [monthly]

    Active Not Recruiting

  7. Sep 2020 — Jan 2021 [monthly]

    Active Not Recruiting

  8. Mar 2020 — Sep 2020 [monthly]

    Active Not Recruiting

  9. Jul 2019 — Mar 2020 [monthly]

    Active Not Recruiting

  10. Mar 2019 — Jul 2019 [monthly]

    Active Not Recruiting

    Status: Recruiting → Active Not Recruiting

  11. Aug 2018 — Mar 2019 [monthly]

    Recruiting

  12. Jun 2018 — Aug 2018 [monthly]

    Recruiting

  13. Apr 2018 — Jun 2018 [monthly]

    Recruiting

    Phase: NA → None

  14. Dec 2017 — Apr 2018 [monthly]

    Recruiting NA

    First recorded

Oct 2017

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Max von Pettenkofer-Institute of the University of Munich (LMU), Department of Virology
  • Michael Hoelscher
  • National Institute for Medical Research - Mbeya Medical Research Centre (NIMR-MMRC)
  • University Clinic of Cologne, Department of Internal Medicine, Center for Molecular Medicine Cologne (CMMC)
Data source: Ludwig-Maximilians - University of Munich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations